Xiaohua Tan, MD, PhD

Director
Department of Oncology and Hematology
Shenzhen Third People’s Hospital
Shenzhen, Guangdong Province, China
Professor
The Second Affiliated Hospital
School of Medicine
Southern University of Science and Technology
Shenzhen, Guangdong Province, China
Vice Chairman
Tumor and Microecology Specialized Committee
China Anti-Tumor Association

Selected publication

1. Ran L, Tan X, Li Y, Zhang H, Ma R, Ji T, Dong W, Tong T, Liu Y, Chen D, Yin X, Liang X, Tang K, Ma J, Zhang Y, Cao X, Hu Z, Qin X, Huang B. Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials. 2016; 89(1):55-66.

2. Tan X, Wan Y. Enhanced protein expression by IRES-driven mRNA translation as a novel approach for in vitro loading dendritic cells with antigens. Human Immunol. 2008, 69(1):32-40.

3. Tan X, Zhang Y, Jiang B, Zhou D. Changes in Ceramide Levels upon Catechins- induced Apoptosis in LoVo Cells. Life Sci. 2002, 70 (17):2023-2029.

4. Tan X, Hu D, Li S, Han Y, Zhang Y, Zhou D. Differences of four catechins in cell cycle arrest and induction of apoptosis in LoVo cells. Cancer Lett. 2000, 158(1):1-6.

5. Lane C, Leitch J, Tan X, Hadjati J, Bramson JL, Wan Y. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res. 2004, 64(4):1509-1514.

6. Zheng FQ, Xu Y, Yang RJ, Wu B, Tan XH, Qin YD, Zhang QW. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. Acta Pharmacol Sin. 2009; 30(5):617-627.